MedPath

Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori

Phase 4
Withdrawn
Conditions
Helicobacter Pylori Gastrointestinal Tract Infection
Interventions
Registration Number
NCT03021590
Lead Sponsor
Damascus Hospital
Brief Summary

Comparison Efficacy of 14-day Concomitant therapy between levofloxacin and Clarithromycin on the Eradication of Helicobacter Pylori in Syrian population

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

-Patients are aged greater than 18 years old who have H. pylori infection diagnosed by any of following three methods: I-Positive rapid urease test (CLOtest). II-Histologic evidence of H. pylori by modified Giemsa staining. III-Positive 13C-urea breath test. without prior eradication therapy and are willing to receive therapy.

Exclusion Criteria
  • Children and teenagers aged less than 18 years.
  • Previous eradication treatment for H. pylori.
  • Patients who took any drug, which could influence the study results such as proton pump inhibitor, H2 blocker, mucosal protective agent and antibiotics.
  • History of gastrectomy.
  • Gastric malignancy, including adenocarcinoma and lymphoma,
  • Previous allergic reaction to antibiotics (Amoxicillin, Tinidazole , Levofloxacin) and prompt pump inhibitors (Es-omeprazole).
  • Contraindication to treatment drugs.
  • Pregnant or lactating women.
  • Severe concurrent disease. Liver cirrhosis. Chronic kidney disease.
  • Patients who cannot give informed consent by himself or herself.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Levofloxacin :Concomitant TherapyLevofloxacin 500Mg Oral TabletLevofloxacin 500 mg Tablets Amoxicillin 1000 mg Tablets,Tinidazole 500 mg Tablets and Esomeprazole 20 mg each every 12 hours for 14 days all by mouth
Clarithromycin :Concomitant TherapyClarithromycin 500Mg Oral TabletAmoxicillin 1000 mg Tablets, Clarithromycin 500 mg Tablets , Tinidazole 500 mg Tablets and Esomeprazole 20 mg Capsule each every 12 hours for 14 days all by mouth
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori Eradication rate6 weeks after eradication therapy

Eradication rate according to Intention to treat (ITT) and per-protocol (PP) analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Damascus Hospital

🇸🇾

Damascus, Syrian Arab Republic

© Copyright 2025. All Rights Reserved by MedPath